ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 14, Issue 1, Pages 4-22
Publisher
Oxford University Press (OUP)
Online
2019-11-02
DOI
10.1093/ecco-jcc/jjz180
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States
- (2019) Kian Keyashian et al. INFLAMMATORY BOWEL DISEASES
- IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology
- (2019) Gareth-Rhys Jones et al. GUT
- IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn’s Disease
- (2019) Stephen B Hanauer et al. Journal of Crohns & Colitis
- Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
- (2019) Nicholas A Kennedy et al. Lancet Gastroenterology & Hepatology
- Perioperative dietary therapy in inflammatory bowel disease
- (2019) Michel Adamina et al. Journal of Crohns & Colitis
- Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn's disease
- (2018) S. Singh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- ACG Clinical Guideline: Management of Crohn’s Disease in Adults
- (2018) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn’s Disease in Sustained Remission
- (2018) Catherine Reenaers et al. Clinical Gastroenterology and Hepatology
- Efficacy of Medical Therapies for Fistulizing Crohn’s Disease: Systematic Review and Meta-Analysis
- (2018) Matthew J. Lee et al. Clinical Gastroenterology and Hepatology
- Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease
- (2018) Geert D’Haens et al. GASTROENTEROLOGY
- Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
- (2018) Julien Kirchgesner et al. GASTROENTEROLOGY
- Modern management of perianal fistulas in Crohn’s disease: future directions
- (2018) Paulo Gustavo Kotze et al. GUT
- Efficacy of Vedolizumab in Fistulising Crohn’s Disease: Exploratory Analyses of Data from GEMINI 2
- (2018) Brian G Feagan et al. Journal of Crohns & Colitis
- Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study
- (2018) Luisa Guidi et al. Journal of Crohns & Colitis
- An indirect comparison of ustekinumab and vedolizumab in the therapy of TNF-failure Crohn's disease patients
- (2018) Paweł Kawalec et al. Journal of Comparative Effectiveness Research
- Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus
- (2018) A Hillary Steinhart et al. INFLAMMATORY BOWEL DISEASES
- Clinical Outcomes With Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Systematic Review With Meta-Analysis
- (2018) Amanda Ricciuto et al. Journal of Crohns & Colitis
- ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detections of complications
- (2018) Christian Maaser et al. Journal of Crohns & Colitis
- Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease
- (2018) Paul Rutgeerts et al. GASTROENTEROLOGY
- Fistula Healing in Pivotal Studies of Ustekinumab in Crohn's Disease
- (2017) Bruce E. Sands et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
- (2017) Joseph D. Feuerstein et al. GASTROENTEROLOGY
- Early intervention in Crohn’s disease: towards disease modification trials
- (2017) Silvio Danese et al. GUT
- Systematic Review and Meta-analysis
- (2017) Jean M. Chalhoub et al. INFLAMMATORY BOWEL DISEASES
- Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohnʼs Disease
- (2017) Stephanie Coward et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease
- (2017) Orlaith B. Kelly et al. INFLAMMATORY BOWEL DISEASES
- Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease
- (2017) Magali Lemaitre et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- DOP001 European Crohn's and Colitis Organisation topical review on environmental factors in IBD
- (2017) C. Maaser et al. Journal of Crohns & Colitis
- European Crohn’s and Colitis Organisation Topical Review on Transitional Care in Inflammatory Bowel Disease
- (2017) Patrick F van Rheenen et al. Journal of Crohns & Colitis
- European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease
- (2017) Glen Doherty et al. Journal of Crohns & Colitis
- Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO]
- (2017) Rotem Sigall-Boneh et al. Journal of Crohns & Colitis
- Crohn's disease
- (2017) Joana Torres et al. LANCET
- Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
- (2017) Jean-Frederic Colombel et al. LANCET
- Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy
- (2017) Julián Panés et al. Nature Reviews Gastroenterology & Hepatology
- Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis
- (2016) N. A. Kennedy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2016) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
- (2016) M J Casanova et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease
- (2016) Nikola Mitrev et al. Expert Opinion On Drug Safety
- Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial
- (2016) Takayuki Matsumoto et al. Journal of Crohns & Colitis
- European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease
- (2016) Florian Rieder et al. Journal of Crohns & Colitis
- ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
- (2016) Silvio Danese et al. Journal of Crohns & Colitis
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
- (2016) Fernando Gomollón et al. Journal of Crohns & Colitis
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations
- (2016) Paolo Gionchetti et al. Journal of Crohns & Colitis
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents
- (2016) Pauliina Molander et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONICpost hocanalysis
- (2015) J.-F. Colombel et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease
- (2015) L. Moja et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Erratum: Corrigendum: Methotrexate in Chronic Active Crohn's Disease: A Double-Blind, Randomized, Israeli Multicenter Trial
- (2015) R Oren et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
- (2015) L Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials
- (2015) Jennifer L. Jones et al. Clinical Gastroenterology and Hepatology
- Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis
- (2015) Glen S. Hazlewood et al. GASTROENTEROLOGY
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
- (2015) Joana Torres et al. GASTROENTEROLOGY
- Does a Personal or Family History of Malignancy Preclude the Use of Immunomodulators and Biologics in IBD
- (2015) Richard S. Kalman et al. INFLAMMATORY BOWEL DISEASES
- European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
- (2015) Vito Annese et al. Journal of Crohns & Colitis
- The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
- (2015) Marcus Harbord et al. Journal of Crohns & Colitis
- Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice
- (2015) Javier Ampuero et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
- (2015) Reena Khanna et al. LANCET
- Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
- (2015) Martin Bortlik et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease
- (2014) R. W. Stidham et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease
- (2014) Heimo H. Wenzl et al. DIGESTIVE DISEASES AND SCIENCES
- Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
- (2014) Bruce E. Sands et al. GASTROENTEROLOGY
- Diagnostic delay in a French cohort of Crohn's disease patients
- (2014) Stéphane Nahon et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2014) J.F. Rahier et al. Journal of Crohns & Colitis
- Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
- (2013) R. Panaccione et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation Rate
- (2013) Alain M Schoepfer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-term Outcome of Perianal Fistulizing Crohn's Disease Treated With Infliximab
- (2013) Guillaume Bouguen et al. Clinical Gastroenterology and Hepatology
- Association Between Plasma Concentrations of Certolizumab Pegol and Endoscopic Outcomes of Patients With Crohn's Disease
- (2013) Jean–Frédéric Colombel et al. Clinical Gastroenterology and Hepatology
- Lymphoma: The Bête Noire of the Long-term Use of Thiopurines in Adult and Elderly Patients With Inflammatory Bowel Disease
- (2013) Laurent Beaugerie GASTROENTEROLOGY
- Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
- (2013) Jacques Cosnes et al. GASTROENTEROLOGY
- Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
- (2013) Julián Panés et al. GASTROENTEROLOGY
- Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
- (2013) Casper Steenholdt et al. GUT
- Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)
- (2013) Pieter Dewint et al. GUT
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
- (2012) Paul Rutgeerts et al. GASTROENTEROLOGY
- Predictive factors for an uncomplicated long-term course of Crohn's disease: A retrospective analysis
- (2012) W. Kruis et al. Journal of Crohns & Colitis
- Efficacy and tolerability of oral budesonide in Japanese patients with active Crohn's disease: A multicentre, double-blind, randomized, parallel-group Phase II study
- (2012) Yasuo Suzuki et al. Journal of Crohns & Colitis
- Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease
- (2012) S. Schreiber et al. Journal of Crohns & Colitis
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2011) Khurram J Khan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
- (2011) Laurent Peyrin–Biroulet et al. GASTROENTEROLOGY
- Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease
- (2011) Stephan R. Vavricka et al. INFLAMMATORY BOWEL DISEASES
- The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
- (2010) S. Lichtiger et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
- (2010) Kelvin T. Thia et al. GASTROENTEROLOGY
- Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease
- (2010) Andreas Tromm et al. GASTROENTEROLOGY
- Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure
- (2010) Ana Echarri et al. Journal of Crohns & Colitis
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Natural History of Adult Crohn's Disease in Population-Based Cohorts
- (2009) Laurent Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
- (2009) Corey A. Siegel et al. Clinical Gastroenterology and Hepatology
- W1096 Results from An Open-Label Extension of CHARM: Steroid-Free Remission in Patients with Crohn's Disease Who Received Adalimumab Therapy for At Least 3 Years
- (2009) Michael A. Kamm et al. GASTROENTEROLOGY
- Adalimumab for the treatment of fistulas in patients with Crohn's disease
- (2009) J-F Colombel et al. GUT
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- A Multicenter, Randomized, Double-Blind Trial of EverolimusVersusAzathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease
- (2008) Walter Reinisch et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
- (2008) Brian G. Feagan et al. Clinical Gastroenterology and Hepatology
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
- Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
- (2008) Gert Van Assche et al. GASTROENTEROLOGY
- Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohnʼs disease: A randomized, double-blind, placebo-controlled pilot study
- (2008) Kelvin T. Thia et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started